Indias REITs Expand Beyond Office Spaces Offering Retail Investors a Stable Income Avenue Retail Investors Gain Direct Access to SpaceX IPO via Major Brokerages INGs AIPowered Trading System Built in Hours Draws Wall Street Attention US Pushes AI Integration in China and Asia Following TrumpXi Summit Three Signs from APEC Indicate US and China Remain Far Apart on Trade Trump Rejects Iran Counterproposal Prolonging Strait of Hormuz Standoff and Energy Market Volatility SNPS Q1 2026 Earnings EPS Beats Estimates Stock Rises 412 WPM Q1 2026 Earnings EPS Beats Expectations on Strong Precious Metals Performance i80 Gold Corp IAUX Q1 2026 Earnings Surprise EPS Beat as Loss Narrows LCI Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain ASST Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid PreRevenue Phase PLBY Q1 2026 Earnings EPS Misses Estimates Stock Climbs Despite Loss CRA International CRAI Holds Near 145 as Modest Pullback Tests Support Zone Mingteng International MTEN Faces Sharp Pullback Tests Key Support at 107 First Seacoast Bancorp FSEA Holds Nearly Flat as Stock Nears Key Support Netflix NFLX Edges Lower Testing Key Support Levels Amid Mixed Sentiment Creative Global Technology Holdings Limited CGTL Slips 6 as Stock Tests Key Support Levels BJs Wholesale Plans Major Store Changes Amid Consumer Spending Pullback LEN Q1 2026 Earnings EPS Misses Estimates as Housing Market Pressures Persist Forafric Global Warrants AFRIW Flat Near Support at 072 Amid Low Volume DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower ESI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises The Travelers Companies TRV Q1 2026 Earnings EPS Beats Estimates Amid Solid Underwriting Performance SCM Q1 2026 Earnings EPS Misses Estimates Despite 153 Stock Gain ABTC Q1 2026 Earnings Earnings Miss Amid Significant EPS Surprise Revenue Absent Arch Capital Group Ltd Depositary Shares Series G ACGLN Q1 2026 Earnings Preferred EPS Slightly Misses Estimates Stock Holds Steady ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development